[1]
Ismail, N.A., Hadil, F.A. and Mohamad, M. 2024. COMPARISON OF DENOSUMAB AND ALENDRONATE EFFICACY AND RELATED DIABETES RISK IN PATIENTS WITH OSTEOPOROSIS. Journal of the ASEAN Federation of Endocrine Societies. 39, S1 (Jul. 2024), 54.